Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone



Similar documents
Cardiac Rehabilitation: Strategies Approaching 2020

Utilization Review Cardiac Rehabilitation Services: Underutilized

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease

The Canadian Association of Cardiac

Protocol. Cardiac Rehabilitation in the Outpatient Setting

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Listen to your heart: Good Cardiovascular Health for Life

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital

Cilostazol versus Clopidogrel after Coronary Stenting

R.P. Zecchin*, J. Baihn, Y.Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, D.L. Ross, C. Chow, A.R. Denniss. Westmead Hospital, Sydney,

Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy

MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: CATEGORY: Therapy/ Rehabilitation

Post-MI Cardiac Rehabilitation. Mark Mason Consultant Cardiologist Harefield Hospital Royal Brompton and Harefield NHS Foundation Trust

Optimizing Value From Cardiac Rehabilitation: A Cost-Utility Analysis Comparing Age, Sex, and Clinical Subgroups

Main Effect of Screening for Coronary Artery Disease Using CT

The Department of Vermont Health Access Medical Policy

RATIONALE AIMS AND FOCUS. International Charter on Cardiovascular Prevention and Rehabilitation: A CALL FOR ACTION PROPOSED VERSION 11 PAGE 01

Performance Measures for. What? When? How?

Prognostic impact of uric acid in patients with stable coronary artery disease

Cardiac Rehab. Home. Do you suffer from a cardiac condition that is limiting your independence in household mobility?

Remote Delivery of Cardiac Rehabilitation

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

For the NXT Investigators

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY

Cardiac Rehabilitation at AUBMC

PCI vs. CABG for Left Main Disease

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

ECG may be indicated for patients with cardiovascular risk factors

Kardiovaskuläre Erkrankungen ein Update für die Praxis, 22. Mai 2014 PD Dr. Matthias Wilhelm

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

PREVENTIVE CARDIOLOGY CURRICULUM. Overview

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

CARDIAC CARE. Giving you every advantage

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Patients with end-stage renal disease (ESRD) are at high

Impact of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Presenter: Praveen N Pakeerappa, MBBS, PGY-3 Department of Physical Medicine and Rehabilitation, University of Kentucky, Lexington, KY

MEDICAL POLICY No R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE

Post discharge tariffs in the English NHS

Substandard Underwriting Structured Settlements

Cardiovascular disease is the leading cause of morbidity

Depression in patients with coronary heart disease (CHD): screening, referral and treatment Na)onal Heart Founda)on of Australia

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Progressive Care Insurance for life A NEW TYPE OF INSURANCE

Medical Fitness. Annual Meeting December By: Deb Riggs, MEd, General Manager

Treatment of cardiogenic shock

KIH Cardiac Rehabilitation Program

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

Xarelto (Rivaroxaban)

The Role Of The Therapist In Cardio-Vascular And Diabetes Rehabilitation

INTRODUCTION TO EECP THERAPY

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

Integrating Cardiac Rehab into your Medical Fitness Program. Bob Brown MPH MBA Manager Heart Wellness Program At Spartanburg Regional Hospital

3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1

PREVENTION IN THE CLINICAL SETTING

06 Validation of risk prediction model

FFR CT : Clinical studies

The Effects of Short-term Cardiac Rehabilitation on Post-CABG Patients Fitness

AACVPR/ACC/AHA Performance Measures

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015

Telemedicine in the Prevention and Monitoring of Heart Disease

Specialty Excellence Award and America s 100 Best Hospitals for Specialty Care Methodology Contents

International Task Force for Prevention Of Coronary Heart Disease. Clinical management of risk factors. coronary heart disease (CHD) and stroke

Cardiac Rehabilitation

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine

Manitoba EMR Data Extract Specifications

Care Coordination. The Embedded Care Manager. Presented by Thomas Decker, MD Mary Finnegan, BSN, M.Ed

Journal of the American College of Cardiology Vol. 38, No. 2, by the American College of Cardiology ISSN /01/$20.

Efficient Evaluation of Chest Pain

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November :38

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

CARDIAC REHABILITATION

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa Objectives. No disclosures, no conflicts

ALBERTA S HEALTH SYSTEM PERFORMANCE MEASURES

CARDIAC RISKS OF NON CARDIAC SURGERY

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, Participating Faculty

ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease

Intensive Cardiac Rehabilitation: Value Creation in Today's FFS World and Reducing Medical Spending in a Value Based Environment

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: 10.

La facilitazione alla PCI con statine

Chapter Three Accountable Care Organizations

Rehabilitation enrollment after cardiac procedures

How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris

ACTION Registry - GWTG: Defect Free Care for Acute Myocardial Infarction Specifications and Testing Overview

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators

Coronary Heart Disease (CHD) Brief

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

Atherosclerosis of the aorta. Artur Evangelista

Perioperative Cardiac Evaluation

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

Your Guide to Express Critical Illness Insurance Definitions

Transcription:

James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary

Acknowledgements and Disclosures Acknowledgements Jacques Genest and Rob Welch National CPG Committee Memberships All of you! Disclosures No Current Industry/Government Funding National CPG Committee Memberships Canadian Diabetes Association 2013 Canadian Cardiac Rehabilitation Cardiac Rehabilitation (Chair) Canadian Hypertension Education Program C-CHANGE (Canadian Cardiovascular HArmonization of National Guidelines Endeavour) (Chair) CCS Dyslipidemia 2102 CCS Smoking Cessation 2011 CCS Committee on Chronic Stable Angina CCS Committee on Refractory Angina Physical Activity for Adults 2011 Physical Activity for Persons with Spinal Cord Dysfunction (Chair) 2011

Cardiac rehabilitation: 1. Improves CAD outcomes 2. No effect on CAD outcomes 3. Is primarily an exercise program 4. Is not cost-effective 5. Is over-utilized in Canada

Something Old,

Something Old "If we could give every individual the right amount of nourishment and exercise, not too little and not too much, we would have found the safest way to health. Hippocrates 460-377 BC

Something Old Superior doctors prevent the disease Mediocre doctors treat the disease before evident Inferior doctors treat the full blown disease Huang Dee: Nai-Chang (2600 BC. 1st Chinese Medical text)

Something Old 10 Studies; N=4347 JAMA 1988;260:945-950

Something Old < 5 METs 5-8 METs > 8 METs Circulation. 2002;106:666-671

Something Old 48 Trials 8940 patients Am J Med. 2004;116:682 692

Something New Cochrane Review 2011 47 studies: 10,794 patients Total Mortality:.87 CI.75-.99 63 Studies; N=21295 Cardiac Mortality:.74 CI.63-.87 One year Readmission:.69 CI.51-.93 Heran et al., Cochrane Database Syst Rev 2011; Jul 6.

Something New 34 RCTs; N = 6,111

N=601,099 Something New Suaya JA, Stason WB, Ades PA, et al. J Am Coll Cardiol. 2009; 54:25-33,

Something New N=5886 Clinical Variables 1. Age 2. Sex 3. Ejection fraction 4. Chronic obstructive pulmonary disease 5. Cerebrovascular disease 6. Elevated creatinine 7. Congestive heart failure 8. Dialysis 9. Hypertension 10. Hyperlipidemia 11. Diabetes mellitus 12. Presence of malignancy 13. Current smoking status 14. Former smoking status 15. Prior myocardial infarction 16. Prior percutaneous coronary intervention 17. Prior coronary artery bypass grafting [CABG] 18. Peripheral vascular disease 19. Liver or gastrointestinal disease 20. Severity of CAD (Duke jeopardy score) 21. Treatment strategy (percutaneous coronary intervention or CABG within 1 year of referral)

Something New Martin BJ et al. Circulation 2012

Something New Eur J Cardiovasc Prev Rehab 2009;16:102-113

Something New

Something New Int J Cardiol 2011;27:355-356

Something New In Press: Mayo Clin Proceed 2013

Something New

Cardiac rehabilitation: 1. Is proven to be cost-effective 2. Is cost-ineffective 3. Is cost-saving 4. Is just a touchy feely kumbaya program

Something Old and New Cost-Effectiveness Potentially cost-saving 1 Highly cost-effective 2-4 < 20,000 per QALY 1. Brown et al 2003 2. Oldridge et al 2008, 2005, 1998 3. Wong et al., 2012 4. CWIC 2013

Something Borrowed CMAJ Oct 2011

Something Borrowed Acronym for Secondary Prevention Stone JA et al. 2009

Cardiac rehabilitation: 1. Has a high attendance rate. 2. Has a high completion rate 3. Is attended more by women 4. Programs mostly serve males

Referrals Cardiac Rehabilitation Something Blue Under Review JACC

Referrals Cardiac Rehabilitation Something Blue Under Review JACC

Something Blue Waiting Times D/C - 65.6 ± 88.4 days Referral - 40.1 ± 73.9 days

Something Blue (or not) Can J Cardiol: 2011

Summary Systematic process-oriented care Treatment target driven Minimizes vascular oxidative stress Maximizing cardiometabolic fitness Reduces recurrent adverse CAD events Yes it does! Principle elements of chronic disease care Patient empowerment

Summary Something Old Something New Something Borrowed Something Blue